|
PEX2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.54720000145048E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.87950005453774E-09 |
| Normal-vs-Stage2 |
6.001100E-04 |
| Normal-vs-Stage3 |
1.304060E-03 |
| Normal-vs-Stage4 |
1.992450E-02 |
| Stage1-vs-Stage2 |
3.713600E-01 |
| Stage1-vs-Stage3 |
1.447780E-01 |
| Stage1-vs-Stage4 |
1.972980E-01 |
| Stage2-vs-Stage3 |
7.538200E-01 |
| Stage2-vs-Stage4 |
5.898400E-01 |
| Stage3-vs-Stage4 |
7.927800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.02639999949506E-07 |
| Normal-vs-AfricanAmerican |
5.72380000063433E-08 |
| Normal-vs-Asian |
1.710400E-02 |
| Caucasian-vs-AfricanAmerican |
7.662400E-01 |
| Caucasian-vs-Asian |
9.774000E-01 |
| AfricanAmerican-vs-Asian |
8.872600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.26390050939563E-10 |
| Normal-vs-Female |
3.579100E-04 |
| Male-vs-Female |
1.345910E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.7212999997861E-07 |
| Normal-vs-Extreme_Weight |
1.37020000012811E-07 |
| Normal-vs-Obese |
1.9451499999934E-05 |
| Normal-vs-Extreme_Obese |
1.362260E-03 |
| Normal_Weight-vs-Extreme_Weight |
9.743400E-01 |
| Normal_Weight-vs-Obese |
2.538600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.580800E-01 |
| Extreme_Weight-vs-Obese |
2.223000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.500400E-01 |
| Obese-vs-Extreme_Obese |
4.219800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.011600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.17569999957823E-07 |
| Normal-vs-Age(61-80Yrs) |
2.44009999983419E-08 |
| Normal-vs-Age(81-100Yrs) |
2.0350999999641E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.323800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.308190E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.674100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.735600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.208400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.063550E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.16179998954635E-09 |
| Normal-VS-Type2 PRCC |
4.82769999532451E-08 |
| Normal-VS-KIRP CIMP |
8.198200E-01 |
| Normal-VS-Unclassified PRCC |
1.96876999999374E-05 |
| Type1 PRCC-VS-Type2 PRCC |
9.843800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.698300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.831200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.766300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.267800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.444200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.84260004423942E-09 |
| Normal-vs-N1 |
1.663210E-01 |
| Normal-vs-N2 |
2.543600E-01 |
| N0-vs-N1 |
4.147900E-02 |
| N0-vs-N2 |
1.248440E-01 |
| N1-vs-N2 |
9.480600E-01 |
|
|
